Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years.

نویسندگان

  • R A Damoiseaux
  • F A van Balen
  • A W Hoes
  • T J Verheij
  • R A de Melker
چکیده

OBJECTIVE To determine the effect of antibiotic treatment for acute otitis media in children between 6 months and 2 years of age. DESIGN Practice based, double blind, randomised, placebo controlled trial. SETTING 53 general practices in the Netherlands. SUBJECTS 240 children aged 6 months to 2 years with the diagnosis of acute otitis media. INTERVENTION Amoxicillin 40 mg/kg/day in three doses. MAIN OUTCOME MEASURES Persistent symptoms at day four and duration of fever and pain or crying, or both. Otoscopy at days four and 11, tympanometry at six weeks, and use of analgesic. RESULTS Persistent symptoms at day four were less common in the amoxicillin group (risk difference 13%; 95% confidence interval 1% to 25%). The median duration of fever was two days in the amoxicillin group versus three in the placebo group (P=0.004). No significant difference was observed in duration of pain or crying, but analgesic consumption was higher in the placebo group during the first 10 days (4.1 v 2.3 doses, P=0.004). In addition, no otoscopic differences were observed at days four and 11, and tympanometric findings at six weeks were similar in both groups. CONCLUSIONS Seven to eight children aged 6 to 24 months with acute otitis media needed to be treated with antibiotics to improve symptomatic outcome at day four in one child. This modest effect does not justify prescription of antibiotics at the first visit, provided close surveillance can be guaranteed.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants

OBJECTIVE To determine the long term effects of antibiotic treatment for acute otitis media in young children. DESIGN Prospective three year follow-up study within the framework of a primary care based, double blind, randomised, placebo controlled trial. SETTING 53 general practices in the Netherlands. PARTICIPANTS 168 children aged 6 months to 2 years with acute otitis media. INTERVENT...

متن کامل

Adenoidectomy versus chemoprophylaxis and placebo for recurrent acute otitis media in children aged under 2 years: randomised controlled trial.

OBJECTIVE To evaluate the efficacy of adenoidectomy compared with long term chemoprophylaxis and placebo in the prevention of recurrent acute otitis media in children aged between 10 months and 2 years. DESIGN Randomised, double blind, controlled trial. SETTING Oulu University Hospital, a tertiary centre in Finland. PARTICIPANTS 180 children aged 10 months to 2 years with recurrent acute ...

متن کامل

Co-amoxiclav in recurrent acute otitis media: placebo controlled study.

OBJECTIVE To determine the efficacy of coamoxiclav in children aged 6 months to 12 years with recurrent acute otitis media. DESIGN A randomised double blind placebo controlled clinical trial. SETTING General practice in the Netherlands. PATIENTS 121 children with recurrent acute otitis media, defined by onset of otalgia and otoscopic signs of middle ear infection within four to 52 weeks a...

متن کامل

A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age.

OBJECTIVES Debate continues with respect to a "watch and wait" approach versus immediate antibiotic treatment for the initial treatment of acute otitis media. In this double-blind noninferiority trial, we compared clinical improvement rates at 14 days for children (6 months to 5 years of age) with acute otitis media who were randomly assigned to receive amoxicillin or placebo. METHODS We enro...

متن کامل

High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media.

Infants and young children, especially those in day care, are at risk for recurrent or persistent acute otitis media (AOM). There are no data on oral alternatives to high-dose amoxicillin-clavulanate for treating AOM in these high-risk patients. In this double-blind, double-dummy multicenter clinical trial, we compared a novel, high-dose azithromycin regimen with high-dose amoxicillin-clavulana...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • BMJ

دوره 320 7231  شماره 

صفحات  -

تاریخ انتشار 2000